Cargando…
Characterization of atrial substrate to predict AF ablation success
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): The study has been financially supported by an investigator-initiated research grant by Biosense Webster (Study ID – IIS-532) (MRM) BACKGROUND: Left atrial (LA) substrate may have mechanistic relevance for ab...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206788/ http://dx.doi.org/10.1093/europace/euad122.001 |
_version_ | 1785046304697614336 |
---|---|
author | Bergonti, M Spera, F Gonzalez Ferrero, T Nsahlai, M Heidbuchel, H Valderrabano, M Rodriguez Manero, M Sarkozy, A |
author_facet | Bergonti, M Spera, F Gonzalez Ferrero, T Nsahlai, M Heidbuchel, H Valderrabano, M Rodriguez Manero, M Sarkozy, A |
author_sort | Bergonti, M |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): The study has been financially supported by an investigator-initiated research grant by Biosense Webster (Study ID – IIS-532) (MRM) BACKGROUND: Left atrial (LA) substrate may have mechanistic relevance for ablation of atrial fibrillation (AF). We sought to analyze the relationship between low-voltage zones (LVZ), transition-zones (TrZ) and AF recurrence in patients undergoing pulmonary vein isolation (PVI). METHODS: We conducted a prospective multicenter study on consecutive patients undergoing PVI-only approach. LVZ and TrZ (0.5-1mV) were analyzed offline on high-density electroanatomical maps collected prior to PVI. RESULTS: 262 patients (61±11 years, 31% female) with paroxysmal (130 pts) or persistent (132 pts) AF were included. After 28 months of follow-up, 73 (28%) patients experienced recurrence. An extension of more than 5% LVZ in paroxysmal AF and more than 15% in persistent AF were associated with recurrence (HR=4.4 [2.0-9.8], p<0.001 and HR=1.9 [1.1-3.7], p=0.045, respectively). Significant linear association was found between LVZ and TrZ and between LVZ and left atrial volume index (LAVI) (both p<0.001). One-third of patients had significantly increased LAVI without LVZ. Eight percent of the patients had LVZ despite normal LAVI. Older age, female sex, oncological history and increased AF recurrence characterized this latter subgroup. CONCLUSIONS: In patients undergoing first PVI, the impact of LVZ on outcomes occurs with lower burden in paroxysmal than persistent AF suggesting that not all LVZs have equal prognostic implications. A proportional area of moderately decreased voltages accompanies LVZ, suggesting a continuous fibrotic substrate instead of the dichotomous division of healthy or diseased tissue. LAVI generally correlates with LVZ but a small subgroup of patients may present with disproportionate atrial remodeling, despite normal LAVI. [Figure: see text] |
format | Online Article Text |
id | pubmed-10206788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102067882023-05-25 Characterization of atrial substrate to predict AF ablation success Bergonti, M Spera, F Gonzalez Ferrero, T Nsahlai, M Heidbuchel, H Valderrabano, M Rodriguez Manero, M Sarkozy, A Europace 10.1 - Pathophysiology and Mechanisms FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): The study has been financially supported by an investigator-initiated research grant by Biosense Webster (Study ID – IIS-532) (MRM) BACKGROUND: Left atrial (LA) substrate may have mechanistic relevance for ablation of atrial fibrillation (AF). We sought to analyze the relationship between low-voltage zones (LVZ), transition-zones (TrZ) and AF recurrence in patients undergoing pulmonary vein isolation (PVI). METHODS: We conducted a prospective multicenter study on consecutive patients undergoing PVI-only approach. LVZ and TrZ (0.5-1mV) were analyzed offline on high-density electroanatomical maps collected prior to PVI. RESULTS: 262 patients (61±11 years, 31% female) with paroxysmal (130 pts) or persistent (132 pts) AF were included. After 28 months of follow-up, 73 (28%) patients experienced recurrence. An extension of more than 5% LVZ in paroxysmal AF and more than 15% in persistent AF were associated with recurrence (HR=4.4 [2.0-9.8], p<0.001 and HR=1.9 [1.1-3.7], p=0.045, respectively). Significant linear association was found between LVZ and TrZ and between LVZ and left atrial volume index (LAVI) (both p<0.001). One-third of patients had significantly increased LAVI without LVZ. Eight percent of the patients had LVZ despite normal LAVI. Older age, female sex, oncological history and increased AF recurrence characterized this latter subgroup. CONCLUSIONS: In patients undergoing first PVI, the impact of LVZ on outcomes occurs with lower burden in paroxysmal than persistent AF suggesting that not all LVZs have equal prognostic implications. A proportional area of moderately decreased voltages accompanies LVZ, suggesting a continuous fibrotic substrate instead of the dichotomous division of healthy or diseased tissue. LAVI generally correlates with LVZ but a small subgroup of patients may present with disproportionate atrial remodeling, despite normal LAVI. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10206788/ http://dx.doi.org/10.1093/europace/euad122.001 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 10.1 - Pathophysiology and Mechanisms Bergonti, M Spera, F Gonzalez Ferrero, T Nsahlai, M Heidbuchel, H Valderrabano, M Rodriguez Manero, M Sarkozy, A Characterization of atrial substrate to predict AF ablation success |
title | Characterization of atrial substrate to predict AF ablation success |
title_full | Characterization of atrial substrate to predict AF ablation success |
title_fullStr | Characterization of atrial substrate to predict AF ablation success |
title_full_unstemmed | Characterization of atrial substrate to predict AF ablation success |
title_short | Characterization of atrial substrate to predict AF ablation success |
title_sort | characterization of atrial substrate to predict af ablation success |
topic | 10.1 - Pathophysiology and Mechanisms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206788/ http://dx.doi.org/10.1093/europace/euad122.001 |
work_keys_str_mv | AT bergontim characterizationofatrialsubstratetopredictafablationsuccess AT speraf characterizationofatrialsubstratetopredictafablationsuccess AT gonzalezferrerot characterizationofatrialsubstratetopredictafablationsuccess AT nsahlaim characterizationofatrialsubstratetopredictafablationsuccess AT heidbuchelh characterizationofatrialsubstratetopredictafablationsuccess AT valderrabanom characterizationofatrialsubstratetopredictafablationsuccess AT rodriguezmanerom characterizationofatrialsubstratetopredictafablationsuccess AT sarkozya characterizationofatrialsubstratetopredictafablationsuccess |